Chromatin Profiling of Epstein-Barr Virus Latency Control Region von DAY, Latasha, CHAU, Charles M, NEBOZHYN, Michael, RENNEKAMP, Andrew J, SHOWE, Michael, LIEBERMAN, Paul M

Volltext

Regulation of Epstein-Barr Virus Latency Type by the Chromatin Boundary Factor CTCF von CHAU, Charles M, ZHANG, Xiao-Yong, MCMAHON, Steven B, LIEBERMAN, Paul M

Volltext

Cell cycle regulation of chromatin at an origin of DNA replication von Zhou, Jing, Chau, Charles M, Deng, Zhong, Shiekhattar, Ramin, Spindler, Mark-Peter, Schepers, Aloys, Lieberman, Paul M

Volltext

Dynamic Chromatin Boundaries Delineate a Latency Control Region of Epstein-Barr Virus von CHAU, Charles M, LIEBERMAN, Paul M

Volltext

Cell Cycle Association of the Retinoblastoma Protein Rb and the Histone Demethylase LSD1 with the Epstein-Barr Virus Latency Promoter Cp von CHAU, Charles M, ZHONG DENG, KANG, Hyojueng, LIEBERMAN, Paul M

Volltext

Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections von Tobin, David M., Roca, Francisco J., Oh, Sungwhan F., McFarland, Ross, Vickery, Thad W., Ray, John P., Ko, Dennis C., Zou, Yuxia, Bang, Nguyen D., Chau, Tran T.H., Vary, Jay C., Hawn, Thomas R., Dunstan, Sarah J., Farrar, Jeremy J., Thwaites, Guy E., King, Mary-Claire, Serhan, Charles N., Ramakrishnan, Lalita

Volltext

Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology) von Blum, Joanne L, Flynn, Patrick J, Yothers, Greg, Asmar, Lina, Geyer, Jr, Charles E, Jacobs, Samuel A, Robert, Nicholas J, Hopkins, Judith O, O'Shaughnessy, Joyce A, Dang, Chau T, Gómez, Henry Leonidas, Fehrenbacher, Louis, Vukelja, Svetislava J, Lyss, Alan P, Paul, Devchand, Brufsky, Adam M, Jeong, Jong-Hyeon, Colangelo, Linda H, Swain, Sandra M, Mamounas, Eleftherios P, Jones, Stephen E, Wolmark, Norman

Volltext

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlle... von Fuchs, Charles S, Dr Prof, Tomasek, Jiri, MD, Yong, Cho Jae, Prof, Dumitru, Filip, MD, Passalacqua, Rodolfo, MD, Goswami, Chanchal, Prof, Safran, Howard, Prof, dos Santos, Lucas Vieira, MD, Aprile, Giuseppe, MD, Ferry, David R, Prof, Melichar, Bohuslav, Prof, Tehfe, Mustapha, MD, Topuzov, Eldar, Prof, Zalcberg, John Raymond, Prof, Chau, Ian, MD, Campbell, William, Prof, Sivanandan, Choondal, MD, Pikiel, Joanna, MD, Koshiji, Minori, MD, Hsu, Yanzhi, PhD, Liepa, Astra M, PharmD, Gao, Ling, PhD, Schwartz, Jonathan D, MD, Tabernero, Josep, MD

Volltext

Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, n... von Herbst, Roy S, Prof, Arkenau, Hendrik-Tobias, MD, Santana-Davila, Rafael, MD, Calvo, Emiliano, MD, Paz-Ares, Luis, Prof, Cassier, Philippe A, MD, Bendell, Johanna, MD, Penel, Nicolas, Prof, Krebs, Matthew G, MD, Martin-Liberal, Juan, MD, Isambert, Nicolas, MD, Soriano, Andres, MD, Wermke, Martin, MD, Cultrera, Jennifer, MD, Gao, Ling, PhD, Widau, Ryan C, PhD, Mi, Gu, PhD, Jin, Jin, PhD, Ferry, David, MD, Fuchs, Charles S, Prof, Petrylak, Daniel P, Prof, Chau, Ian, MD

Volltext

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer von Ng, King Pan, Hillmer, Axel M, Chuah, Charles T H, Juan, Wen Chun, Ko, Tun Kiat, Teo, Audrey S M, Ariyaratne, Pramila N, Takahashi, Naoto, Sawada, Kenichi, Fei, Yao, Soh, Sheila, Lee, Wah Heng, Huang, John W J, Allen, John C, Woo, Xing Yi, Nagarajan, Niranjan, Kumar, Vikrant, Thalamuthu, Anbupalam, Poh, Wan Ting, Ang, Ai Leen, Mya, Hae Tha, How, Gee Fung, Yang, Li Yi, Koh, Liang Piu, Chowbay, Balram, Chang, Chia-Tien, Nadarajan, Veera S, Chng, Wee Joo, Than, Hein, Lim, Lay Cheng, Goh, Yeow Tee, Zhang, Shenli, Poh, Dianne, Tan, Patrick, Seet, Ju-Ee, Ang, Mei-Kim, Chau, Noan-Minh, Ng, Quan-Sing, Tan, Daniel S W, Soda, Manabu, Isobe, Kazutoshi, Nöthen, Markus M, Wong, Tien Y, Shahab, Atif, Ruan, Xiaoan, Cacheux-Rataboul, Valère, Sung, Wing-Kin, Tan, Eng Huat, Yatabe, Yasushi, Mano, Hiroyuki, Soo, Ross A, Chin, Tan Min, Lim, Wan-Teck, Ruan, Yijun, Ong, S Tiong

Volltext

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor models von Wyce, Anastasia, Ganji, Gopinath, Smitheman, Kimberly N, Chung, Chun-Wa, Korenchuk, Susan, Bai, Yuchen, Barbash, Olena, Le, BaoChau, Craggs, Peter D, McCabe, Michael T, Kennedy-Wilson, Karen M, Sanchez, Lydia V, Gosmini, Romain L, Parr, Nigel, McHugh, Charles F, Dhanak, Dashyant, Prinjha, Rab K, Auger, Kurt R, Tummino, Peter J

Volltext

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised... von Hoglund, Richard M, Pyae Phyo, Aung, Lek, Dysoley, Anvikar, Anupkumar R, Satpathi, Parthasarathi, Satpathi, Sanghamitra, Behera, Prativa Kumari, Tripura, Amar, Baidya, Subrata, Chau, Nguyen Hoang, Sovann, Yok, Mao, Sivanna, Oun, Savuth, Yen, Sovannary, Amaratunga, Chanaki, Saelow, Chalermpon, Runcharern, Ratchadaporn, Kaewmok, Weerayuth, Hanboonkunupakarn, Borimas, Mohanty, Akshaya Kumar, Heaton, James, Thant, Myo, Gantait, Kripasindhu, Ghosh, Tarapada, Amato, Roberto, Jacob, Christopher G, Gonçalves, Sónia, Waithira, Naomi, Grobusch, Martin P, van Vugt, Michele, Fairhurst, Rick M, Cheah, Phaik Yeong, Dhorda, Mehul, Maude, Richard J, Winterberg, Markus, Thuy-Nhien, Nguyen Thanh, Kwiatkowski, Dominic P, Jittamala, Podjanee, Lin, Khin, Chotivanich, Kesinee, Huy, Rekol, Ashley, Elizabeth, Mayxay, Mayfong, Newton, Paul N, Hien, Tran Tinh, Valecha, Neena, Smithuis, Frank, Faiz, Abul, Miotto, Olivo, Tarning, Joel, Day, Nicholas P J, White, Nicholas J, van der Pluijm, Rob W, Hoglund, Richard M, Phyo, Aung Pyae, ul Islam, Akhter, Anvikar, Anupkumar R, Satpathi, Parthasarathi, Behera, Prativa Kumari, Tripura, Amar, Baidya, Subrata, Onyamboko, Marie, Chau, Nguyen Hoang, Sovann, Yok, Sreng, Sokunthea, Oun, Savuth, Amaratunga, Chanaki, Chutasmit, Kitipumi, Saelow, Chalermpon, Hoa, Nhu Thi, Thanh, Ngo Viet, Hanboonkunupakarn, Borimas, Callery, James J, Heaton, James, Thant, Myo, Gantait, Kripasindhu, Ghosh, Tarapada, Woodrow, Charles J, Grobusch, Martin P, van Vugt, Michele, Fairhurst, Rick M, Cheah, Phaik Yeong, Peto, Thomas J, von Seidlein, Lorenz, Maude, Richard J, Winterberg, Markus, Kwiatkowski, Dominic P, Imwong, Mallika, Jittamala, Podjanee, Lin, Khin, Hlaing, Tin Maung, Chotivanich, Kesinee, Ashley, Elizabeth, Newton, Paul N, Hien, Tran Tinh, Faiz, Abul, Miotto, Olivo, Tarning, Joel, Day, Nicholas PJ, Dondorp, Arjen M

Volltext

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-bli... von Zhu, Andrew X, Dr, Park, Joon Oh, MD, Ryoo, Baek-Yeol, MD, Yen, Chia-Jui, MD, Poon, Ronnie, MD, Pastorelli, Davide, MD, Blanc, Jean-Frederic, MD, Chung, Hyun Cheol, MD, Baron, Ari D, MD, Pfiffer, Tulio Eduardo Flesch, MD, Okusaka, Takuji, MD, Kubackova, Katerina, MD, Trojan, Jorg, MD, Sastre, Javier, PhD, Chau, Ian, MD, Chang, Shao-Chun, MD, Abada, Paolo B, MD, Yang, Ling, MS, Schwartz, Jonathan D, MD, Kudo, Masatoshi, MD

Volltext

Contemporary trends in necrotizing soft-tissue infections in the United States von Psoinos, Charles M., MD, Flahive, Julie M., MS, Shaw, Joshua J., MD, Li, YouFu, MD, MPH, Ng, Sing Chau, MS, Tseng, Jennifer F., MD, MPH, Santry, Heena P., MD, MS

Volltext

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Can... von Fernandez-Martinez, Aranzazu, Krop, Ian E, Hillman, David W, Polley, Mei-Yin, Parker, Joel S, Huebner, Lucas, Hoadley, Katherine A, Shepherd, Jonathan, Tolaney, Sara, Henry, N Lynn, Dang, Chau, Harris, Lyndsay, Berry, Donald, Hahn, Olwen, Hudis, Clifford, Winer, Eric, Partridge, Ann, Perou, Charles M, Carey, Lisa A

Volltext

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of... von Tsai, Chiaojung Jillian, Yang, Jonathan T, Shaverdian, Narek, Patel, Juber, Shepherd, Annemarie F, Eng, Juliana, Guttmann, David, Yeh, Randy, Gelblum, Daphna Y, Namakydoust, Azadeh, Preeshagul, Isabel, Modi, Shanu, Seidman, Andrew, Traina, Tiffany, Drullinsky, Pamela, Flynn, Jessica, Zhang, Zhigang, Rimner, Andreas, Gillespie, Erin F, Gomez, Daniel R, Lee, Nancy Y, Berger, Michael, Robson, Mark E, Reis-Filho, Jorge S, Riaz, Nadeem, Rudin, Charles M, Powell, Simon N, Berger, Michael, Bromberg, Jacqueline, Chen, Linda, Dang, Chau, Das, Jeeban P, Drullinsky, Pamela, Eng, Julianna, Flynn, Jessica, Gelblum, Daphna Y, Gillespie, Erin F, Girshman, Jeffrey, Gomez, Daniel R, Gucalp, Ayca, Guttmann, David, Hajj, Carla, Higginson, Daniel, Iqbal, Afsheen, Khan, Atif J, LaPlant, Quincey, Lee, Nancy Y, Mann, Justin M, Modi, Shanu, Namakydoust, Azadeh, Ng, Kenneth, Patel, Juber, Powell, Simon N, Preeshagul, Isabel, Reis-Filho, Jorge S, Reyngold, Marsha, Riaz, Nadeem, Rimner, Andreas, Robson, Mark E, Rudin, Charles M, Sanford, Rachel, Seidman, Andrew D, Shah, Ronak, Shaverdian, Narek, Shepherd, Annemarie F, Shin, Jacob Y, Sugarman, Steven, Traina, Tiffany A, Tsai, Chiaojung Jillian, Wu, Abraham J, Xu, Amy J, Yang, Jonathan T, Yeh, Randy, Zhang, Zhigang, Zhi, Wanqing

Volltext

Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer von Langston, Steven P, Grossman, Stephen, England, Dylan, Afroze, Roushan, Bence, Neil, Bowman, Douglas, Bump, Nancy, Chau, Ryan, Chuang, Bei-Ching, Claiborne, Christopher, Cohen, Larry, Connolly, Kelly, Duffey, Matthew, Durvasula, Nitya, Freeze, Scott, Gallery, Melissa, Galvin, Katherine, Gaulin, Jeffrey, Gershman, Rachel, Greenspan, Paul, Grieves, Jessica, Guo, Jianping, Gulavita, Nanda, Hailu, Shumet, He, Xingyue, Hoar, Kara, Hu, Yongbo, Hu, Zhigen, Ito, Mitsuhiro, Kim, Mi-Sook, Lane, Scott Weston, Lok, David, Lublinsky, Anya, Mallender, William, McIntyre, Charles, Minissale, James, Mizutani, Hirotake, Mizutani, Miho, Molchinova, Nina, Ono, Koji, Patil, Ashok, Qian, Mark, Riceberg, Jessica, Shindi, Vaishali, Sintchak, Michael D, Song, Keli, Soucy, Teresa, Wang, Yana, Xu, He, Yang, Xiaofeng, Zawadzka, Agatha, Zhang, Ji, Pulukuri, Sai M

Volltext

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Canc... von Tanioka, Maki, Fan, Cheng, Parker, Joel S, Hoadley, Katherine A, Hu, Zhiyuan, Li, Yan, Hyslop, Terry M, Pitcher, Brandelyn N, Soloway, Matthew G, Spears, Patricia A, Henry, Lynn N, Tolaney, Sara, Dang, Chau T, Krop, Ian E, Harris, Lyndsay N, Berry, Donald A, Mardis, Elaine R, Winer, Eric P, Hudis, Clifford A, Carey, Lisa A, Perou, Charles M

Volltext

The Identification of Enteric Fever-Specific Antigens for Population-Based Serosurveillance von Mylona, Elli, Hefele, Lisa, Tran Vu Thieu, Nga, Trinh Van, Tan, Nguyen Ngoc Minh, Chau, Tran Tuan, Anh, Karkey, Abhilasha, Dongol, Sabina, Basnyat, Buddha, Voong Vinh, Phat, Ho Ngoc Dan, Thanh, Russell, Paula, Charles, Richelle C, Parry, Christopher M, Baker, Stephen

Volltext

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis von Rajasekhar, Megha, Simpson, Julie A, Ley, Benedikt, Edler, Peta, Chu, Cindy S, Abreha, Tesfay, Awab, Ghulam R, Baird, J Kevin, Bancone, Germana, Barber, Bridget E, Grigg, Matthew J, Hwang, Jimee, Karunajeewa, Harin, Lacerda, Marcus V G, Ladeia-Andrade, Simone, Llanos-Cuentas, Alejandro, Pukrittayakamee, Sasithon, Rijal, Komal R, Saravu, Kavitha, Sutanto, Inge, Taylor, Walter R J, Thriemer, Kamala, Watson, James A, Guerin, Philippe J, White, Nicholas J, Price, Ric N, Commons, Robert J

Volltext